Showing results (641-650 of 931) with videos related to

Sort By:
Pageof 94
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 4, 2024
The Impact of Acute Exercise on Hemostasis and Angiogenesis Mediators in Patients With Continuous-Flow Left Ventricular Assist Devices: A Prospective Observational Pilot StudyChris H H Chan, Margaret R Passmore, Oystein Tronstad, et al.
Circulation|May 27, 2022
Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac TransplantationChris Anthony, Muhammad Imran, Jim Pouliopoulos, et al.
Heart, Lung & Circulation|May 19, 2020
COVID-19 and Acute Heart Failure: Screening the Critically Ill - A Position Statement of the Cardiac Society of Australia and New Zealand (CSANZ)Sean Lal, Christopher S Hayward, Carmine De Pasquale, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 13, 2018
A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathyClaire Horvat, Renee Johnson, Lien Lam, et al.
Circulation. Genomic and Precision Medicine|September 6, 2023
DMD-Associated Dilated Cardiomyopathy: Genotypes, Phenotypes, and PhenocopiesRenee Johnson, Robyn Otway, Ephrem Chin, et al.
American Heart Journal|September 5, 2024
Long term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trialsSheldon E Litwin, Jan Komtebedde, Barry A Borlaug, et al.
BMJ Neurology Open|September 26, 2025
Integrated UPper limb and Language Impairment and Functional Training (UPLIFT) after stroke: study protocol for an umbrella Bayesian Optimal Phase IIa clinical trialKathryn S Hayward, Geoffrey Donnan, Erin Godecke, et al.
JACC. Heart Failure|June 10, 2026
Heart Failure Duration, Cardiac Remodeling, Dysfunction, and Hemodynamic Severity in HFpEF and HFmrEF: Insights From REDUCE LAP-HF IIShunichi Doi, Sho Kazui, Naoyuki Akashi, et al.
Eclinicalmedicine|January 29, 2025
SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocolsMoreno Ursino, Guillermo Villacampa, Jan Rekowski, et al.
Eclinicalmedicine|January 29, 2025
CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trialsJan Rekowski, Christina Guo, Olga Solovyeva, et al.
Pageof 94